BRIEF published on 02/27/2025 at 12:41, 1 year ago ECJ Ruling Impacts DocMorris Advertising Strategy DocMorris AG ECJ Ruling Prescription Medicine Discounts German Court Case Advertising Regulations
PRESS RELEASE published on 02/27/2025 at 12:36, 1 year ago DocMorris AG: ECJ Ruling on advertising for prescription medicines DocMorris AG: ECJ ruling permits Rx discount promotions with vouchers for beauty and personal care products. Company to focus on digitalization and e-prescriptions growth in Germany Digitalization DocMorris AG ECJ Ruling Prescription Medicines Discount Promotions
BRIEF published on 01/21/2025 at 07:03, 1 year 2 months ago DocMorris Reports 6.7% Growth in 2024 with Strong Rx Revenue Surge 2024 Financial Results DocMorris Growth Rx Revenue Increase TeleClinic Performance German Market Trends
PRESS RELEASE published on 01/21/2025 at 06:58, 1 year 2 months ago DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter DocMorris grows 6.7% in 2024 with increased Rx sales, OTC revenues and TeleClinic profits. Achieved revenue target and positive cash position. Outlook confirmed for 2024 Revenue Growth DocMorris Rx Sales TeleClinic OTC Revenues
BRIEF published on 10/15/2024 at 07:03, 1 year 5 months ago DocMorris Accelerates Prescription Medicine Growth Revenue Growth Telehealth DocMorris AG Prescription Medicine Logistics Closure
PRESS RELEASE published on 10/15/2024 at 06:58, 1 year 5 months ago DocMorris accelerates Rx growth DocMorris accelerates Rx growth with a 12.2% revenue increase in Q3, new CTO appointed, and logistics site closure in Germany. Strong growth in e-prescriptions and customer base E-prescriptions DocMorris CTO Appointment Rx Growth Logistics Site Closure
BRIEF published on 08/20/2024 at 07:03, 1 year 7 months ago DocMorris Enhances Prescription Business and Boosts New Rx Customer Investment 2024 Outlook E-prescriptions DocMorris Prescription Business TeleClinic
PRESS RELEASE published on 08/20/2024 at 06:58, 1 year 7 months ago DocMorris grows in the prescription business and invests incrementally in new Rx customers DocMorris reports growth in prescription business and increased investments in new Rx customers. Break-even reached, outlook for 2024 adjusted due to e-prescription transition Financial Results E-prescriptions New Customers DocMorris Prescription Business
BRIEF published on 07/11/2024 at 07:03, 1 year 8 months ago DocMorris Reports Significant eRx Growth in Q2 2024 Revenue Increase Market Expansion DocMorris ERx Growth
PRESS RELEASE published on 07/11/2024 at 06:58, 1 year 8 months ago DocMorris with accelerated and significant eRx growth in new customers, market share and revenue DocMorris reports accelerated eRx growth in new customers, market share, and revenue, with significant progress in eRx business and expanding customer base Revenue Market Share DocMorris ERx Growth CardLink
Published on 03/26/2026 at 16:20, 15 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 3 hours 35 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 3 hours 35 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 3 hours 36 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 16:20, 14 minutes ago Sartorius AG Supervisory Board extends appointment of board member René Fáber
Published on 03/26/2026 at 15:25, 1 hour 10 minutes ago Duck Creek Loss Control Named 2026 Insurance Luminary Finalist by PropertyCasualty360
Published on 03/26/2026 at 15:23, 1 hour 12 minutes ago Sartorius AG - Resolutions of the Annual General Meeting
Published on 03/26/2026 at 15:05, 1 hour 30 minutes ago JOY GROUP Announces 2025 Financial Results, Revenue Surpasses US$620M
Published on 03/26/2026 at 15:01, 1 hour 33 minutes ago EQS-Adhoc: CENIT AG decides to switch from the Regulated Market (Prime Standard) to the Scale Segment of the Frankfurt Stock Exchange
Published on 03/26/2026 at 07:30, 9 hours 5 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 22 hours 4 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 22 hours 50 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
